IRWD
Ironwood Pharmaceuticals Inc
4.10$
-1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +95.7% | +83.2% | +8.9% | +16.2% | +23.6% | -9.1% | +6.2% | -0.8% | +7.8% | -20.6% | -15.7% | |
| – | -100.0% | +15,466.7% | +938.9% | +68.8% | +313.4% | -97.7% | +2,145.1% | -98.0% | +333.6% | +22.8% | -75.1% | |
| – | +194.1% | +81.9% | +2.5% | +12.6% | -6.6% | +31.9% | -11.1% | +19.2% | +6.7% | -21.2% | -13.9% | |
| – | +6.7% | +28.3% | +6.3% | +12.3% | -26.6% | -28.0% | -20.1% | -37.1% | +162.3% | -4.0% | -14.6% | |
| – | +5.8% | +38.4% | +34.5% | +3.5% | -28.5% | -18.8% | -20.6% | +4.4% | +27.6% | -2.5% | -43.0% | |
| – | +6.3% | +34.1% | +23.5% | +7.3% | -58.4% | +40.8% | -54.4% | +43.0% | +770.1% | -81.9% | -29.3% | |
| – | – | – | – | – | – | +19.0% | +62.5% | +7.8% | -477.7% | – | +27.5% | |
| – | +46.9% | +25.9% | -7.1% | +3.7% | -3.0% | -19.5% | +5.7% | -75.6% | +184.7% | +52.7% | -0.9% | |
| – | – | – | – | – | – | +84.7% | +84.3% | +25.8% | -475.6% | – | +7.4% | |
| – | +121.8% | +99.7% | -9.8% | -116.8% | – | -96.4% | -12,308.2% | – | +7.9% | -23.0% | -28.5% | |
| – | – | – | – | – | – | +393.7% | +397.7% | -66.9% | -672.5% | – | +2,629.2% | |
| – | – | – | – | – | – | +10.4% | +64.7% | +11.9% | -24.5% | -50.5% | +7.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.